(2S,3R)-2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one

Details

Top
Internal ID b73c0715-8cbf-4424-9cb0-f451cc7d8980
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavans > Flavanones > Flavanonols
IUPAC Name (2S,3R)-2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one
SMILES (Canonical) C1=CC(=C(C=C1O)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O
SMILES (Isomeric) C1=CC(=C(C=C1O)O)[C@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O
InChI InChI=1S/C15H12O7/c16-6-1-2-8(9(18)3-6)15-14(21)13(20)12-10(19)4-7(17)5-11(12)22-15/h1-5,14-19,21H/t14-,15-/m0/s1
InChI Key QIWOFDHUQPJCJF-GJZGRUSLSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H12O7
Molecular Weight 304.25 g/mol
Exact Mass 304.05830272 g/mol
Topological Polar Surface Area (TPSA) 127.00 Ų
XlogP 1.50
Atomic LogP (AlogP) 1.19
H-Bond Acceptor 7
H-Bond Donor 5
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,3R)-2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9499 94.99%
Caco-2 - 0.9494 94.94%
Blood Brain Barrier - 0.8250 82.50%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Mitochondria 0.6122 61.22%
OATP2B1 inhibitior - 0.6706 67.06%
OATP1B1 inhibitior + 0.9133 91.33%
OATP1B3 inhibitior - 0.5697 56.97%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.8764 87.64%
P-glycoprotein inhibitior - 0.8766 87.66%
P-glycoprotein substrate - 0.8967 89.67%
CYP3A4 substrate + 0.5211 52.11%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7873 78.73%
CYP3A4 inhibition + 0.7241 72.41%
CYP2C9 inhibition + 0.8948 89.48%
CYP2C19 inhibition + 0.6434 64.34%
CYP2D6 inhibition - 0.9083 90.83%
CYP1A2 inhibition + 0.9108 91.08%
CYP2C8 inhibition - 0.6932 69.32%
CYP inhibitory promiscuity + 0.7652 76.52%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6985 69.85%
Eye corrosion - 0.9903 99.03%
Eye irritation + 0.9665 96.65%
Skin irritation + 0.6294 62.94%
Skin corrosion - 0.9563 95.63%
Ames mutagenesis + 0.5300 53.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8060 80.60%
Micronuclear + 0.9400 94.00%
Hepatotoxicity + 0.5875 58.75%
skin sensitisation - 0.7817 78.17%
Respiratory toxicity + 0.6111 61.11%
Reproductive toxicity + 0.7667 76.67%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.5594 55.94%
Acute Oral Toxicity (c) II 0.6238 62.38%
Estrogen receptor binding + 0.5664 56.64%
Androgen receptor binding + 0.6334 63.34%
Thyroid receptor binding + 0.7007 70.07%
Glucocorticoid receptor binding + 0.8313 83.13%
Aromatase binding + 0.5970 59.70%
PPAR gamma + 0.7039 70.39%
Honey bee toxicity - 0.8946 89.46%
Biodegradation - 0.9000 90.00%
Crustacea aquatic toxicity + 0.5800 58.00%
Fish aquatic toxicity + 0.8967 89.67%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.02% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.21% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.54% 89.00%
CHEMBL2581 P07339 Cathepsin D 90.95% 98.95%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 90.33% 99.23%
CHEMBL3192 Q9BY41 Histone deacetylase 8 89.48% 93.99%
CHEMBL1929 P47989 Xanthine dehydrogenase 89.46% 96.12%
CHEMBL3401 O75469 Pregnane X receptor 88.26% 94.73%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.05% 86.33%
CHEMBL2535 P11166 Glucose transporter 85.14% 98.75%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 84.67% 99.15%
CHEMBL4530 P00488 Coagulation factor XIII 83.96% 96.00%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 82.09% 93.40%

Cross-Links

Top
PubChem 98049813
NPASS NPC6501
LOTUS LTS0096236
wikiData Q105222442